BAJAJ BROKING

Notification
No new Notification messages
Ather Energy IPO is Open!
Apply for the Ather Energy IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

Sun Pharmaceuticals Industries ltd Dividend: History, Yield & Payout Details

Listen to our Podcast: Grow your wealth and keep it secure.

0:00 / 0:00

Introduction

Sun Pharmaceuticals Industries Ltd. is one of India’s largest and most respected pharmaceutical companies, with a strong global presence. It manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients (APIs) across various therapeutic segments. The company has a solid reputation for innovation, quality, and compliance, contributing to its consistent growth over the years.

Apart from its operational performance, Sun Pharma also focuses on rewarding its shareholders. It has a history of consistent dividend declarations, reflecting its commitment to delivering value. This article explores the company's dividend yield, payout patterns, dividend policy, and guidance for shareholders to check or claim dividends.

Sun Pharmaceuticals Industries Ltd. Dividend Overview

  • Latest Dividend Declared: On January 16, 2025, the company announced an interim dividend of ₹10.50 per share.​
  • Dividend Yield: As of April 2, 2025, the dividend yield is approximately 0.79%. ​
  • Record Date: The record date for the latest dividend was February 6, 2025.
  • Ex-Dividend Date: The ex-dividend date for the interim dividend was February 6, 2025.
  • Payout Ratio: The company has maintained a dividend payout ratio of 34%. ​

Sun Pharmaceuticals Industries Ltd. Dividend History

Year

Dividend Per Share (₹)

Payout (%)

2024

13.50

34

2023

11.50

33

2022

10.00

73

2021

7.50

62

2020

4.00

25

2019

2.75

25

Sun Pharmaceuticals Industries Ltd. Dividend Yield & Financial Performance

Sun Pharmaceuticals has maintained a dividend policy that aligns with its profitability and operational strength. As of March 2024, the company declared a dividend of ₹13.50 per share. The basic earnings per share (EPS) during the same period stood at ₹11.06. While the dividend yield varies with market price movements, the company’s payout trends indicate a steady commitment to rewarding shareholders.

The dividend payout ratio was around 34%, which signifies that a moderate portion of earnings was returned to shareholders while the rest was retained for business expansion and reserves. Sun Pharma’s financial performance over the years continues to support its ability to declare consistent dividends without compromising long-term growth.

Sun Pharmaceuticals Industries Ltd. Dividend Policy & Factors Affecting It

Sun Pharmaceuticals follows a balanced and transparent dividend policy. The primary factors influencing this policy include the company's profitability, availability of free cash flows, and future business expansion needs. With a dividend payout ratio of 46.6%, the company signals a healthy approach—rewarding shareholders while retaining funds for research, development, and strategic acquisitions.

The management also considers market conditions, capital expenditure plans, and regulatory obligations when finalising the dividend. This dynamic and responsive strategy ensures that dividends are sustainable, financially viable, and aligned with shareholder expectations. As a result, Sun Pharma has built a reputation for responsible dividend distribution supported by sound financial principles.

How to Check & Claim Dividends?

Shareholders can check dividend announcements and payment statuses through the company's official website or financial news portals. Dividends are typically credited directly to the shareholder's registered bank account. If dividends are not received, shareholders should contact the company's investor relations department or their respective brokerage firm.​

Conclusion & Investment Takeaways

Sun Pharmaceuticals Industries Ltd. has consistently rewarded shareholders through dividend declarations, with a payout ratio of 46.6% reflecting both profitability and fiscal prudence. The company’s ability to generate returns while maintaining robust R&D and global expansion underscores its financial strength and investor focus.

For potential and existing investors, analysing Sun Pharma’s dividend history alongside its earnings, growth trajectory, and market conditions can offer insights into future returns. While dividend income is a valuable component, it should be assessed within the broader context of total returns and business sustainability before making investment decisions.

Disclaimer: Investments in the securities market are subject to market risk, read all related documents carefully before investing.

This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.

For All Disclaimers Click Here: https://www.bajajbroking.in/disclaimer

Share this article: 

Frequently Asked Questions

No result found

search icon

Read More Blogs

Disclaimer :

The information on this website is provided on "AS IS" basis. Bajaj Broking (BFSL) does not warrant the accuracy of the information given herein, either expressly or impliedly, for any particular purpose and expressly disclaims any warranties of merchantability or suitability for any particular purpose. While BFSL strives to ensure accuracy, it does not guarantee the completeness, reliability, or timeliness of the information. Users are advised to independently verify details and stay updated with any changes.

The information provided on this website is for general informational purposes only and is subject to change without prior notice. BFSL shall not be responsible for any consequences arising from reliance on the information provided herein and shall not be held responsible for all or any actions that may subsequently result in any loss, damage and or liability. Interest rates, fees, and charges etc., are revised from time to time, for the latest details please refer to our Pricing page.

Neither the information, nor any opinion contained in this website constitutes a solicitation or offer by BFSL or its affiliates to buy or sell any securities, futures, options or other financial instruments or provide any investment advice or service.

BFSL is acting as distributor for non-broking products/ services such as IPO, Mutual Fund, Insurance, PMS, and NPS. These are not Exchange Traded Products. For more details on risk factors, terms and conditions please read the sales brochure carefully before investing.

Investments in the securities market are subject to market risk, read all related documents carefully before investing. This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.

[ Read More ]

For more disclaimer, check here : https://www.bajajbroking.in/disclaimer

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

9.5 lakh+ Users

icon-with-text

4+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4400+ Cr MTF Book

icon-with-text